CD79b anticorps (PE)

N° du produit ABIN135812

Détail du produit anti-CD79b anticorps (PE)

Antigène: CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD79b est conjugé à/à la PE

Application: Flow Cytometry (FACS)

Specificité: Human CD79b, Mr 37 kDa

Attributs du produit: Mouse Anti-Human CD79b-PE

Purification: Ion exchange column

Immunogène: Ramos B cells

Clone: CB3-1

Isotype: IgG1

Information d'application

Indications d'application:

• Applications: FC - Quality tested , IP - Reported in literature , WB - Reported in literature
• Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC, BIOT, PE, APC, and SPRD conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L

Restrictions: For Research Use only

Stockage

Buffer: 100 tests in 1.0 mL of PBS/Sodium azide and a stabilizing agent

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Do not freeze!
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C

Détails sur CD79b

Antigène: CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))

Autre désignation: CD79b (CD79B Produits)

Synonymes: anticorps B29, anticorps Ig-beta, anticorps Igb, anticorps Igbeta, anticorps AGM6, anticorps IGB, anticorps CD79B antigen, anticorps CD79b molecule, anticorps Cd79b, anticorps CD79B

Sujet: CD79 is a 23/21 disulfide-linked heterodimer composed of an chain (CD79a/mb-1) and a chain (CD79b/B29) that associates non-covalently with membrane immunoglobulin to form the B cell receptor (BCR) complex. Its expression is restricted to B lymphocytes, first appearing on the surface at the pro-B cell stage and remaining through all stages of B cell differentiation prior to plasma cells. Crosslinking of the BCR leads to B cell activation.

Pathways: BCR Signaling